EuropaBio is engaged in dialogue with the
European Parliament, the
European Commission, and the
Council of Ministers to influence legislation on biotechnology. EuropaBio represents two sectors of the biotech industry. • White or
industrial biotechnology is the application of biotechnology for industrial purposes, including manufacturing, alternative energy (or "bioenergy") biofuels, and biomaterials. • Red or
healthcare biotechnology is the application of biotechnology for the production of medicines and therapies. EuropaBio's stated goals are: • promoting an innovative, coherent, and dynamic biotechnology-based industry in Europe; • advocating free and open markets and the removal of barriers to competitiveness with other areas of the world; • committing to an open, transparent, and informed dialogue with all stakeholders about the ethical, social, and economic aspects of biotechnology and its benefits; • championing the socially responsible use of biotechnology to ensure that its potential is fully used to the benefit of humans and their environment. EuropaBio's primary focus is the
European Union but because of the global character of the biotech business, it also represents its members in transatlantic and worldwide forums. ==Organisation==